TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the upcoming schedule of presentations highlighting BRIUMVI ® (ublituximab-xiiy), to be presented (ACTRIMS) annual forum, being held February 5 – ...

Cognitive impairment is more common and severe in older adults with MS than in younger patients, but this is driven by ...

Columnist Ben Hofmeister likens the three battlefield ways to degrade an adversary's abilities to the disruptions caused by ...

Many symptoms of MS are the same as those of other conditions. If you are concerned that you may have MS, make an appointment with your primary care provider. They will discuss your concerns and do a ...

Large Norwegian registry data links birth size and maternal diabetes with higher multiple sclerosis risk, suggesting prenatal ...

The Canadian biotechnology firm Bionxt Solutions has reported encouraging preclinical results for its proprietary drug delivery system. The company’s oral thin film (ODF) formulation of Cladribin, an ...

Cannabis use may impair the ability of people with multiple sclerosis to accurately self-assess their cognitive performance.

—Using CDC data, researchers in Pakistan have found that annual age-adjusted mortality rates due to multiple sclerosis in the U.S. rose between 1999 and 2020, a trend that was observed across both ...

Briumvi is a medicine used to treat relapsing forms of multiple sclerosis (MS). Relapsing forms of MS include clinically isolated syndrome, relapsing-remitting MS, and active secondary progressive MS.

Nearly 1 million people in the United States have MS, and there’s a thriving community of like-minded people dedicated to finding a cure and helping people live their best life while managing the ...

Multiple sclerosis (MS) is a chronic autoimmune disorder of the central nervous system, including the brain, spinal cord, and optic nerves. The body mistakenly attacks and damages the protective ...